| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/09/2004 | US20040175365 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175361 Modulator of desmosomal cadherin-mediated cell adhesion using a Trp(tryptophan)-containing cell adhesion recognition sequence; anticarcinogenic, antitumor, and antimetastasis agents |
| 09/09/2004 | US20040175359 Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity |
| 09/09/2004 | US20040175358 Side effect reduction using oxidized glutathione GSSG-reductase and glutathione peroxidase; reduced toxicity during chemotherapy |
| 09/09/2004 | US20040175357 IL-2 selective agonists and antagonists |
| 09/09/2004 | US20040175355 Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals |
| 09/09/2004 | US20040173527 Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process |
| 09/09/2004 | DE10308107A1 New macrocyclic peptide derivatives useful for treating bacterial infections, especially caused by Gram-positive bacteria |
| 09/09/2004 | DE10226702A1 Antisense Oligonukleotide gegen PIM1 Antisense oligonucleotides against PIM1 |
| 09/09/2004 | DE10212892A9 Konstrukte und Verfahren zur Regulation der Genexpression Constructs and methods for regulation of gene expression |
| 09/08/2004 | EP1455190A1 Modulation of the activity of nuclear receptors via EWS |
| 09/08/2004 | EP1454985A2 Modulators of receptors of the tnf/ngf receptor family |
| 09/08/2004 | EP1454984A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 09/08/2004 | EP1454982A1 Mtehod of analyzing gene expression |
| 09/08/2004 | EP1454917A2 Diabody-type bispecific antibody |
| 09/08/2004 | EP1454916A1 Modified cDNA factor VIII and its derivatives |
| 09/08/2004 | EP1454914A1 Tumor antigen |
| 09/08/2004 | EP1454640A2 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 09/08/2004 | EP1454633A1 Cosmetic or pharmaceutical composition for topical use to prevent or treat androgenetic alopecia |
| 09/08/2004 | EP1454632A1 Pharmaceutical preparation for the treatment of blood-clotting disorders containing factor VIII derived peptides |
| 09/08/2004 | EP1454631A1 Oral insulin composition and methods of making and using thereof |
| 09/08/2004 | EP1454630A1 Long acting injectable insulin composition and methods of making and using thereof |
| 09/08/2004 | EP1454629A2 Insulinotrophic agent based on preproglucagon |
| 09/08/2004 | EP1454628A2 Medical use of p38/JTV-1 |
| 09/08/2004 | EP1454627A1 Alpha-Keto carbonyl calpain inhibitors |
| 09/08/2004 | EP1454145A2 Method for the assessment and prognosis of sarcoidosis |
| 09/08/2004 | EP1454138A2 Immunocytokines with modulated selectivity |
| 09/08/2004 | EP1453966A1 Method for producing a recombinant polypeptide |
| 09/08/2004 | EP1453962A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 09/08/2004 | EP1453862A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 09/08/2004 | EP1453860A2 Novel glucose-dependant insulins |
| 09/08/2004 | EP1453859A2 Chemically-modified human growth hormone conjugates |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453855A1 Antimicrobial bolisin peptides |
| 09/08/2004 | EP1453852A2 Selective urokinase inhibitors |
| 09/08/2004 | EP1453849A2 Antisense modulation of purinoreceptor p2x3 |
| 09/08/2004 | EP1453816A2 Phenoxy amine compounds and compositions for delivering active agents |
| 09/08/2004 | EP1453803A2 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
| 09/08/2004 | EP1453534A1 A process for the preparation of a non-toxic anthrax vaccine |
| 09/08/2004 | EP1453533A1 Migration of hematopoietic stem cells and progenitor cells to th e liver |
| 09/08/2004 | EP1453531A2 Use of hmgb proteins and nucleic acids that code therefor |
| 09/08/2004 | EP1453530A2 Method of proliferation in neurogenic regions |
| 09/08/2004 | EP1453529A2 Treatment of sepsis with tafi |
| 09/08/2004 | EP1453528A2 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 09/08/2004 | EP1453527A2 Method for obtaining oestrogen from mare urine |
| 09/08/2004 | EP1453525A1 Selective targeting of apoptotic cells |
| 09/08/2004 | EP1453520A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/08/2004 | EP1453513A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
| 09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 09/08/2004 | EP1453500A1 Styryl acrylonitrile compounds and their use to promote myelopoiesis |
| 09/08/2004 | EP1453467A2 Methods and compositions for modulating apoptosis |
| 09/08/2004 | EP1453388A1 Methods and compositions for use in pet breeding |
| 09/08/2004 | EP1409510A4 Biological pacemaker |
| 09/08/2004 | EP1231931B1 Methods of treating inflammatory bowel disease using cholera toxin b subunit |
| 09/08/2004 | EP1207896A4 Methods and compositions for reducing serum phosphate levels |
| 09/08/2004 | EP1180121B9 Long lasting insulinotropic peptides |
| 09/08/2004 | EP1174501B1 Gene expression base sequences for therapeutic use and drugs for gene therapy |
| 09/08/2004 | EP1164992A4 Methods and compositions for enhancing fibroblast migration |
| 09/08/2004 | EP1137662B1 Pharmaceutical compositions comprising quinapril magnesium |
| 09/08/2004 | EP1131087B1 Methods of alleviating cancer symptoms |
| 09/08/2004 | EP1126870B1 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 09/08/2004 | EP1075281B1 Polyol-ifn-beta conjugates |
| 09/08/2004 | EP1064021B1 Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis. |
| 09/08/2004 | EP1039874B1 Compositions and methods for treatment of alopecia |
| 09/08/2004 | EP1001802B1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
| 09/08/2004 | EP0991426B1 Method for transferring nucleic acid into the striated muscle |
| 09/08/2004 | EP0975370B9 Composition and method for enhancing transport across biological membranes |
| 09/08/2004 | EP0960127A4 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/08/2004 | EP0922099B1 Fas ligand-like protein, its production and use |
| 09/08/2004 | EP0892852B1 Encapsulated cells expressing cytochrome p450 for prodrug activation |
| 09/08/2004 | EP0835127B1 Composition containing a myelin-associated glycoprotein (mag) inhibitor which comprises an altered or mutated form of mag |
| 09/08/2004 | EP0763009B1 Photocleavable conjugates for the detection and isolation of biomolecules |
| 09/08/2004 | EP0758232B1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 09/08/2004 | EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 09/08/2004 | CN1527879A Nucleic acid and protein sequences of bovine epidermal growth factor |
| 09/08/2004 | CN1527878A Shingolipid ceramide deacylase gene |
| 09/08/2004 | CN1527839A Modified human brain-derived neutrophic factor (BDNF) with reduced immunogenicity |
| 09/08/2004 | CN1527727A Improved chelator conjugates |
| 09/08/2004 | CN1527723A Methods for treating or preventing skin disorders using CD2-binding agents |
| 09/08/2004 | CN1527721A Compositions comprising mixtures of human cytokines and methods of producing the same |
| 09/08/2004 | CN1527719A Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 09/08/2004 | CN1527718A Method for short-term and long-term drug dosimetry |
| 09/08/2004 | CN1527716A Anti-virus agent |
| 09/08/2004 | CN1527698A 控释可生物降解的凝胶基质 Controlled release biodegradable gel matrix |
| 09/08/2004 | CN1527689A Insert for the treatment of dry eye |
| 09/08/2004 | CN1526818A Method of blocking expression of hepatitis B virus |
| 09/08/2004 | CN1526815A Common phytase |
| 09/08/2004 | CN1526737A Molt-inhibiting hormone-1 protein of mitten crab |
| 09/08/2004 | CN1526736A N-end fusion protein PC-1-e2 of human multicapsular protein-1 |
| 09/08/2004 | CN1526730A Erythrocytosis factor and its production process |
| 09/08/2004 | CN1526725A Antitumor polypeptide and its application |
| 09/08/2004 | CN1526448A Medicine and method for the treatment of anorectal disorders |
| 09/08/2004 | CN1526445A Application of snake venom L-amino acid oxidase in preparing AIDS treating medicine |
| 09/08/2004 | CN1526372A Long-acting injection capable of inhibiting abrupt release effect |
| 09/08/2004 | CN1165764C Anti PSMA antibody or antigen binding part, and their use |
| 09/08/2004 | CN1165617C Oligonucleotides for inhibiting expression of human eg5 |
| 09/08/2004 | CN1165547C Novel lantibiotic related to actagardine, and process for preparation and use thereof |